Zolpidem for Insomnia: A Double-Edged Sword. A Systematic Literature Review on Zolpidem-Induced Complex Sleep Behaviors.

Niti Mittal, Rakesh Mittal, M C Gupta
Author Information
  1. Niti Mittal: Dept. of Pharmacology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. ORCID
  2. Rakesh Mittal: Dept. of Pharmacology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.
  3. M C Gupta: Dept. of Pharmacology, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India.

Abstract

BACKGROUND: Being a nonbenzodiazepine, zolpidem is believed to have a favorable side-effect profile and is widely prescribed for insomnia. However, in the past few years, numerous neuropsychiatric adverse reactions, particularly complex sleep behaviors (CSBs), have been reported with zolpidem.
OBJECTIVE: To conduct a systematic review of zolpidem-associated CSBs.
DATA SOURCES: An electronic search was conducted using MEDLINE, Embase, PubMed, and Cochrane database of systematic reviews to extract relevant articles till July 2020.
STUDY ELIGIBILITY CRITERIA: Any type of literature article (case report, case series, and observational or interventional study) reporting CSBs associated with zolpidem.
RESULTS: In this review, we present aggregate summarized data from 148 patients presenting with zolpidem-induced CSBs (79 patients from 23 case reports and 5 case series; 69 patients out of 1454 taking zolpidem [4.7%] from three observational clinical studies). Various types of CSBs associated with zolpidem were reported, most common being sleepwalking/somnambulism and sleep-related eating disorder. On causality assessment, around 88% of cases were found to have a probable association with zolpidem.
LIMITATIONS: Extraction of data from observational studies and spontaneous reports, due to nonavailability of any randomized controlled trials relevant to the study objective.
CONCLUSION AND IMPLICATION OF KEY FINDINGS: Zolpidem-induced CSBs, although not very common, may develop when the drug is used at therapeutic doses for insomnia. Doctors need to be alert to monitor such adverse effects of zolpidem and exercise caution while prescribing it.

Keywords

References

Clin Psychopharmacol Neurosci. 2016 Aug 31;14(3):299-301 [PMID: 27489385]
Sleep Med. 2009 Feb;10(2):262-4 [PMID: 19059805]
J Clin Sleep Med. 2007 Oct 15;3(6):637-8 [PMID: 17993047]
J Clin Psychopharmacol. 2019 May/Jun;39(3):189-199 [PMID: 30939589]
J Neurol Sci. 2010 Jan 15;288(1-2):200-1 [PMID: 19822330]
Neuropsychiatr Dis Treat. 2013;9:1159-62 [PMID: 23976857]
Prim Care Companion J Clin Psychiatry. 2005;7(2):74 [PMID: 15841201]
J Clin Sleep Med. 2017 Feb 15;13(2):223-234 [PMID: 27784418]
JBI Evid Synth. 2020 Oct;18(10):2127-2133 [PMID: 33038125]
J Diet Suppl. 2013 Dec;10(4):381-90 [PMID: 24237192]
J Clin Sleep Med. 2011 Dec 15;7(6):632-8 [PMID: 22171202]
Prim Care Companion CNS Disord. 2012;14(4): [PMID: 23251862]
BMJ Case Rep. 2013 Feb 21;2013: [PMID: 23436890]
Int J Eat Disord. 2009 May;42(4):385-6 [PMID: 19107832]
Sleep Med. 2002 Jul;3(4):323-7 [PMID: 14592194]
Neurol Sci. 2005 Dec;26 Suppl 3:s225-32 [PMID: 16331401]
Br J Clin Pharmacol. 1986 Feb;21(2):205-11 [PMID: 3954937]
Ann Pharmacother. 2003 Oct;37(10):1429-33 [PMID: 14519043]
J Clin Sleep Med. 2009 Oct 15;5(5):471-6 [PMID: 19961034]
Eur Neuropsychopharmacol. 2009 Jan;19(1):74-6 [PMID: 18819779]
Int J Legal Med. 2015 Jan;129(1):85-8 [PMID: 24770472]
Clin Neuropharmacol. 2013 Sep-Oct;36(5):173-4 [PMID: 24045611]
Am J Med. 2008 Nov;121(11):e5 [PMID: 18954831]
Clin Toxicol (Phila). 2007;45(2):179-81 [PMID: 17364638]
CNS Drugs. 2008;22(12):1021-36 [PMID: 18998740]
J Clin Psychiatry. 2014 Nov;75(11):e1314-8 [PMID: 25470097]
Psychiatry Clin Neurosci. 2007 Apr;61(2):207-8 [PMID: 17362446]
Med Hypotheses. 2011 Aug;77(2):230-3 [PMID: 21565448]
Clin Pharmacokinet. 1995 Sep;29(3):142-53 [PMID: 8521677]
J Clin Psychopharmacol. 1994 Apr;14(2):150 [PMID: 8195460]
Indian J Psychol Med. 2015 Jan-Mar;37(1):105-6 [PMID: 25722525]
J Clin Psychiatry. 2010 Oct;71(10):1331-5 [PMID: 20441722]
Fukuoka Igaku Zasshi. 2015 Jun;106(6):202-5 [PMID: 26306385]
Nat Rev Neurosci. 2005 Jun;6(6):477-83 [PMID: 15928717]
J Clin Sleep Med. 2008 Apr 15;4(2):155-6 [PMID: 18468314]
J Psychiatr Res. 2000 Nov-Dec;34(6):423-38 [PMID: 11165310]
Gen Hosp Psychiatry. 2008 Jan-Feb;30(1):90-1 [PMID: 18164949]
Arch Phys Med Rehabil. 2005 Jun;86(6):1265-6 [PMID: 15954071]
Indian J Med Ethics. 2018 Jul-Sep;3(3):192-195 [PMID: 29699955]
J Sleep Res. 2011 Dec;20(4):559-68 [PMID: 21481053]
Prim Care Companion J Clin Psychiatry. 2010;12(6): [PMID: 21494350]
J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):211-2 [PMID: 15725964]
Neurologia. 2010 Oct;25(8):491-7 [PMID: 20965000]
J Int Med Res. 1995 Jan-Feb;23(1):61-73 [PMID: 7774760]
Psychosomatics. 2011 Jan-Feb;52(1):88-91 [PMID: 21300202]
Medicina (B Aires). 2010;70(3):223-6 [PMID: 20529770]
Drugs. 2000 Apr;59(4):865-89 [PMID: 10804040]

Word Cloud

Similar Articles

Cited By